Articles tagged with: AIDSmap

People taking ART in the UK have an accurate understanding of their viral load

published: January, 26, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Gay Men, Treatment Guidelines -including when to start, General Health, International , Sexual Health, Revolving Door, Treatment, Guest Authors

Overall, 96% of people who told researchers their viral load was undetectable had a clinic-recorded viral load below 50 copies/ml, with 99% having a viral load below 1000 copies/ml. For AIDSmap.com, Michael Carter reports on new study.

People taking ART in the UK have an accurate understanding of their viral load

The vast majority of people taking antiretroviral therapy (ART) in the UK have an accurate knowledge of their current viral load (VL) level, investigators report in HIV Medicine. Overall, 96% of people who told researchers their viral load was undetectable had a clinic-recorded viral load below 50 copies/ml, with 99% having a viral load below 1000 copies/ml. “The accuracy of reporting an undetectable VL [viral load] by HIV-positive individuals on ART is directly relevant to their HIV

Dutch model finds PrEP for high-risk gay men is cost-effective at current prices and cost-saving at generic prices

published: October, 10, 2016 Written by // Guest Authors - Revolving Door Categories // Gay Men, As Prevention , Treatment Guidelines -including when to start, Research, Health, International , Revolving Door, Treatment, Guest Authors

From AIDSmap, Gus Cairns: "Applying generic rather than on-patent prices turned PrEP in most scenarios from cost-effective to cost-saving."

Dutch model finds PrEP for high-risk gay men is cost-effective at current prices and cost-saving at generic prices

A mathematical modelling study based on the HIV epidemic in the Netherlands has found that daily pre-exposure prophylaxis (PrEP) would be cost-effective even at current drug prices if it was targeted at gay men at high risk of HIV infection. In a base case where PrEP was 80% effective, 10% of higher-risk gay men took it, current drug prices were used, and PrEP was taken every day, then PrEP’s cost per quality-adjusted life year (QALY) gained would be €11,000. This would fall to only €20

Realism needed about the benefits and risks of taking part in HIV cure studies

published: September, 16, 2016 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Social Media, General Health, Research, Health, International , Sexual Health

There is “an ethical imperative to understand the motivations, decision‐making, expectations and comprehension of potential trial participants,” researchers say." From AIDSmap, Roger Pebody explains

Realism needed about the benefits and risks of taking part in HIV cure studies

A significant proportion of people living with HIV would be willing to take part in a study towards a cure for HIV, research presented at the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa last month shows. However, some potential participants may not fully understand that taking part in an early-phase study is highly unlikely to afford any personal clinical benefit, but might have the potential to cause harm. There is “an ethical imperative to understand the motiv

Depression increases risk of heart attack for adults with HIV

published: September, 09, 2016 Written by // Guest Authors - Revolving Door Categories // Social Media, General Health, Mental Health, Research, Health, International , Revolving Door, Guest Authors

From AIDSmap, Michael Carter reports on the Veterans Aging Cohort Study

Depression increases risk of heart attack for adults with HIV

Major depression is associated with an increased risk of heart attack for middle-aged HIV-positive people, investigators from the United States report in JAMA Cardiology. Overall, presence of a major depressive disorder (MDD) increased the risk of heart attack – acute myocardial infarction (AMI) – by almost a third. Use of antidepressants weakened the association between depression and heart attack risk, and there was no evidence that milder forms of depression – dysthymic disorders –

High Court rules NHS England is responsible for funding PrEP

published: August, 03, 2016 Written by // Guest Authors - Revolving Door Categories // Social Media, Gay Men, Current Affairs, Treatment Guidelines -including when to start, General Health, Health, International , Sexual Health, Legal, Treatment, Revolving Door, Guest Authors

The ruling does not mean PrEP will succeed as a candidate for funding. From AIDSmap, Keith Alcorn reports

High Court rules NHS England is responsible for funding PrEP

This article by Keith Alcorn previously appeared at AIDSmap.com here.   A judicial review in the High Court has ruled that NHS England is responsible for funding pre-exposure prophylaxis (PrEP) and decisively rebutted all the arguments used by NHS England to avoid paying for the use of PrEP. NHS England said today in response that the High Court ruling does not mean the medication will end up being funded by the NHS, and warned today that manufacturer Gilead Sciences now faces a bli

World’s largest study of HIV self-testing gets off the ground

published: July, 29, 2016 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Social Media, African, Caribbean and Black, General Health, Research, Health, Sexual Health, International , Revolving Door, Guest Authors

From AIDSmap, Roger Pebody reports on the STAR Research Project, a study of the many concerns related to HIV self-testing kits.

World’s largest study of HIV self-testing gets off the ground

Early data from STAR, the largest study yet of HIV self-testing, suggests that there is a strong demand for self-testing in rural Zimbabwe, the 21st International AIDS Conference (AIDS 2016) heard this week. Other studies examined whether self-testing kits can help the male partners of pregnant women to test and whether such use might sometimes be coercive. The World Health Organization (WHO) defines HIV self-testing as “a process in which an individual who wants to know his or her HIV st

Gay men report a wide range of behaviours to make sex safer

published: July, 01, 2016 Written by // Guest Authors - Revolving Door Categories // Social Media, Gay Men, Research, Health, International , Sexual Health

From aidsmap, Roger Pebody reports on how gay men in the UK are reducing risk of HIV transmission - including avoiding sex with poz guys!.

Gay men report a wide range of behaviours to make sex safer

Gay men in the UK employ a wide range of precautionary tactics and behaviors to avoid harms during sex – using condoms is just one of the ways in which men protect themselves and their partners. Avoiding sex with partners of a different HIV status, knowing their current viral load, using lubricant for intercourse and regular testing were all widely cited behaviours.   The data come from the 2014 Gay Men’s Sex Survey, released yesterday. The report also highlights gaps in men’s knowledg

US on course to end its HIV epidemic – eventually

published: May, 19, 2016 Written by // Guest Authors - Revolving Door Categories // Health, International , Sexual Health, Revolving Door, Treatment, Living with HIV, Guest Authors

Aidsmap reports, "Fall in new infections only achieves half of 2010 target"

US on course to end its HIV epidemic – eventually

This article by Gus Cairns first appeared on aidsmap.com here. If current trends continue, the US may eventually end its HIV epidemic, a mathematical model recently published in AIDS & Behavior shows. In 2009, the average number of people each person with HIV would infect during their lifetime fell below one, and has now declined to 0.75, the model shows. This means the number of people with HIV will eventually start to shrink, as more in the ageing HIV-positive population start to die

New British guidelines recommend treatment for everyone with HIV

published: June, 26, 2015 Written by // Guest Authors - Revolving Door Categories // Revolving Door, Guest Authors

Aidsmap reports everyone with HIV who is prepared to take antiretroviral treatment should receive it, regardless of CD4 cell count, new draft British HIV Association (BHIVA) treatment guidelines recommend.

New British guidelines recommend treatment for everyone with HIV

This article previously appeared  in HIV Update, a publication of Aidsmap.com, here.  Anyone living with HIV who understands the commitment of treatment and is ready to start should receive treatment, according to the draft guidelines. The decision to start treatment rests with the person living with HIV. The change from a recommendation to start treatment before the CD4 cell count falls below 350 cells/mm3 to treatment for all follows the results of the START trial, a keenly awaited inter

Does it work? A summary of the current evidence on the efficacy of treatment as prevention

published: March, 02, 2014 Written by // Bob Leahy - Publisher Categories // Activism, As Prevention , Research, Health, International , Sexual Health, Treatment, Living with HIV, Bob Leahy - Publisher

How much do we know? This is an article designed to inform the debate on Treatment as Prevention. Read it in conjunction with “The community speaks on Treatment as Prevention.”

Does it work? A summary of the current evidence on the efficacy of treatment as prevention

From aidsmap.com/Europen AIDS Treatment Group. This article looks at the evidence for the biological and cohort‐level efficacy of treatment as prevention: it does not look at the effectiveness of different ways of using ART as part of a co‐ordinated HIV prevention strategy.  Transmission via vaginal sex. A number of observational studies had already established that transmission of HIV from people on suppressive ART appeared to be a rare event.In 2011, the HPTN052 study looked at HIV

<<  1 2 3 4 [56 7 8  >>